|
Market Closed -
Boerse Muenchen
16:44:02 2026-09-01 EDT
|
5-day change | 1st Jan Change | ||
| 107.65 EUR | +1.37% |
|
-2.32% | +27.93% |
| 08-31 | Incyte Corporation Enters Agreement with U.S. Centers for Medicare & Medicaid Services | CI |
| 08-28 | US FDA approves Takeda, Protagonist's drug for rare blood cancer | RE |
| Market Cap | 24.98B 21.55B 20.27B 18.48B 34.7B 2,371B 34.95B 240B 93.29B 1,205B 93.77B 91.73B 4,000B | P/E 2026 * |
55.8x | P/E 2027 * | 17.3x |
|---|---|---|---|---|---|
| Enterprise Value | 20.75B 17.9B 16.84B 15.35B 28.83B 1,970B 29.03B 200B 77.49B 1,001B 77.89B 76.19B 3,323B | EV / Sales 2026 * |
3.49x | EV / Sales 2027 * | 3.03x |
| Free-Float |
98.16% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript : Incyte Corporation
| 1 week | -3.15% | ||
| 1 month | +2.91% | ||
| 3 months | +27.66% | ||
| 6 months | +24.11% | ||
| Current year | +26.79% |
| 1 week | 105.7 |  | 111.85 |
| 1 month | 100.75 | | 111.85 |
| 3 years | 46.98 | | 116.25 |
| 5 years | 46.98 | | 116.25 |
| 10 years | 0 | | 144.55 |
| Manager | Title | Age | Since |
|---|---|---|---|
William Meury
CEO | Chief Executive Officer | 58 | 2025-06-25 |
Suketu Upadhyay
DFI | Director of Finance/CFO | 57 | 2026-05-03 |
Pablo Cagnoni
PSD | President | 62 | 2023-06-04 |
| Director | Title | Age | Since |
|---|---|---|---|
Julian Baker
CHM | Chairman | 59 | 2025-06-25 |
| Director/Board Member | 72 | 2015-01-19 | |
Paul Clancy
BRD | Director/Board Member | 64 | 2015-01-19 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.37% | -2.32% | +47.34% | +78.55% | 24.98B | |
| +3.10% | -0.56% | +41.87% | -0.32% | 79.79B | |
| +0.43% | +1.89% | -19.06% | -37.01% | 58.85B | |
| +9.93% | +11.07% | +540.39% | +36.44% | 56.03B | |
| +0.13% | -3.37% | -1.24% | +34.14% | 51.26B | |
| +1.49% | -0.68% | +9.33% | +163.89% | 47.68B | |
| -0.28% | -0.95% | +63.39% | -19.20% | 32.01B | |
| +1.45% | -2.32% | +47.75% | +93.72% | 24.98B | |
| -2.12% | +2.11% | +4.90% | +189.46% | 23.05B | |
| +1.69% | +1.19% | +59.26% | +116.16% | 16.31B | |
| Average | +0.44% | -0.99% | +79.39% | +65.58% | 43.33B | |
| Weighted average by Cap. | +0.63% | -1.51% | +92.45% | +46.64% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 5.94B 5.13B 4.82B 4.4B 8.26B 564B 8.31B 57.15B 22.19B 287B 22.31B 21.82B 952B | 6.27B 5.4B 5.09B 4.64B 8.71B 595B 8.77B 60.25B 23.4B 302B 23.52B 23.01B 1,003B |
| Net income | 466M 402M 378M 345M 647M 44.23B 652M 4.48B 1.74B 22.48B 1.75B 1.71B 74.61B | 1.5B 1.29B 1.21B 1.11B 2.08B 142B 2.09B 14.39B 5.59B 72.2B 5.62B 5.49B 240B |
| Net Debt | -4.23B -3.65B -3.43B -3.13B -5.88B -402B -5.92B -40.68B -15.8B -204B -15.88B -15.53B -677B | -5.99B -5.17B -4.86B -4.43B -8.32B -569B -8.38B -57.62B -22.38B -289B -22.49B -22B -959B |
| Date | Price | Change |
|---|---|---|
| 26-09-01 | €107.65 | +1.37% |
| 26-08-31 | €106.20 | -0.89% |
| 26-08-28 | €107.15 | -2.19% |
| 26-08-27 | €109.55 | -0.77% |
| 26-08-26 | €110.40 | -0.81% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- INCY Stock
- ICY Stock
Select your edition
All financial news and data tailored to specific country editions
